Bexsero Market Report 2026

Bexsero Market Overview

• The Bexsero market growth in the historic period has been driven by outbreaks of meningococcal disease, pediatric vaccination initiatives • Market expansion is supported by expansion of adolescent vaccination, increased public health funding • Growth Driver: Rising Meningitis Prevalence Boosts Bexsero Market Growth • Market Trend: Advancements In Meningococcal B Vaccine Development For Broader Protection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bexsero Market?

Bexsero refers to a meningococcal group B vaccine designed to help prevent invasive meningococcal disease caused by Neisseria meningitidis group B bacteria. It is used for active immunization in individuals aged 2 months and older to protect against meningitis and septicemia caused by this bacterial strain. The main types of bexsero formulations include injectable suspension and pre-filled syringes. An injectable suspension is a liquid preparation containing finely divided particles of a drug suspended in a liquid medium, intended for injection. It is distributed through hospitals, pharmacy stores, and public health programs and is used by adults, geriatrics, adolescents, and children.

What Is The Bexsero Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of adolescent vaccination, increased public health funding, improved vaccine coverage, outbreak preparedness strategies, global immunization initiatives. Major trends in the forecast period include expansion of meningococcal vaccination programs, increased focus on pediatric immunization, government led public health campaigns, rising awareness of invasive meningococcal disease, integration into national immunization schedules.

Global Bexsero Market Segmentation

1) By Formulation: Injectable Suspension, Pre-Filled Syringes 2) By Distribution: Hospitals, Pharmacy Stores, Public Health Programs 3) By End User: Adults, Geriatric, Adolescents, Children

What Are The Drivers Of The Bexsero Market?

The increasing prevalence of meningitis is expected to propel the growth of the bexsero market going forward. Meningitis is the inflammation of the protective membranes surrounding the brain and spinal cord, usually due to an infection. The increasing prevalence of meningitis can be attributed to several factors, including higher infection rates, changes in vaccination coverage, weakened immunity, and improved detection and reporting systems. Bexsero helps protect against meningitis by stimulating the immune system to produce antibodies specifically targeting Neisseria meningitidis group B bacteria, thereby reducing the risk of invasive meningococcal disease, which can cause life-threatening inflammation of the brain and spinal cord membranes. For instance, in August 2024, according to the UK Health Security Agency (UKHSA), the meningococcal reference unit confirmed 378 cases of invasive meningococcal disease (IMD) in 2024-25, up from 341 cases in 2023-24. Therefore, the increasing prevalence of meningitis is driving the growth of the bexsero industry. The increasing research and development activities are expected to propel the growth of the bexsero market going forward. Research and development activities involve the systematic exploration and development of new knowledge, products, or technologies through research and experimentation. Research and development activities are increasing due to the growing demand for innovative solutions to address emerging health threats and improve treatment efficacy. Research and development activities are beneficial for Bexsero as they enable the optimization of its formulation, enhance its efficacy and safety profile, and support the expansion of its applications to broader populations and emerging meningococcal strains. For instance, in July 2025, according to Eurostat, a Luxembourg-based statistical agency, the total government budget allocations for R&D across the EU reached an estimated €127,916 million in 2024, marking a 3.4% increase compared with €123,675 million in 2023. Therefore, the increasing research and development activities is driving the growth of the bexsero industry.

Key Players In The Global Bexsero Market

Major companies operating in the bexsero market are GlaxoSmithKline plc

Global Bexsero Market Trends and Insights

Major companies operating in the Bexsero market are focusing on developing advanced solutions, such as meningococcal B vaccines, to broaden protection against multiple strains within serogroup B. Meningococcal B vaccines are designed to prevent infections caused by Neisseria meningitidis serogroup B, a bacterium responsible for invasive meningococcal disease, including meningitis and bloodstream infections. For instance, in July 2024, GlaxoSmithKline (GSK) Plc, a UK-based pharmaceutical company, launched the Bexsero vaccine in South Korea. It contains four key components recombinant proteins NHBA, NadA, fHbp, and the outer membrane vesicle PorA P1.4. These components were chosen based on the complete genetic analysis of meningococcal B. This formulation triggers the production of bactericidal antibodies that target multiple mechanisms of meningococcal B antigens.

Regional Insights

North America was the largest region in the bexsero market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Bexsero Market?

The bexsero market consists of sales of meningococcal vaccines, pneumococcal vaccines, hepatitis vaccines, influenza vaccines and travel vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bexsero Market Report 2026?

The bexsero market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bexsero industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.